| Net sales | 67,477.99a | 61,615.85a |
| Cost of goods sold | -57,057.84a | -53,341.34a |
| Gross profit | 10,420.16a | 8,274.51a |
| Gain (loss) arising from changes in fair value of biological assets | 294.32a | -65.1a |
| Selling expenses | -2,491.85a | -2,350.95a |
| General and administrative expenses | -2,138.64a | -1,979.25a |
| Other operating income | 295.27a | 100.05a |
| Other operating expenses | -391.83a | -324.66a |
| Operating profit | 5,987.42a | 3,654.61a |
| Finance costs | -731.65a | -697.72a |
| Gain (loss) on foreign exchange | -43.44a | 11.89a |
| Finance income | 44.03a | 28.12a |
| Profit before income tax | 5,256.35a | 2,996.89a |
| Income tax expense | -1,544.75a | -678.8a |
| Profit for the year | 3,711.6a | 2,318.09a |
| Profit for the year attributable to | — | — |
| Owners of the parent | 3,712.93a | 2,318.58a |
| Non-controlling interest | -1.33a | -0.5a |
| Total | 3,711.6a | 2,318.09a |